Continuous epoprostenol (prostacyclin) infusion improves both portopulmonary hypertension and hepatic function.

被引：0
|
作者：
Merriman, RB [1 ]
Demarco, T [1 ]
Bass, NM [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1936
引用
收藏
页码：A377 / A377
页数：1
相关论文
共 50 条
  • [1] Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension
    Kuo, PC
    Johnson, LB
    Plotkin, JS
    Howell, CD
    Bartlett, ST
    Rubin, LJ
    TRANSPLANTATION, 1997, 63 (04) : 604 - 606
  • [2] Chronic intravenous infusion of epoprostenol reverses portopulmonary hypertension
    Kuo, PC
    Johnson, LB
    Plotkin, JS
    Njoku, M
    Howell, CD
    Bartlett, ST
    Rubin, LJ
    HEPATOLOGY, 1996, 24 (04) : 1210 - 1210
  • [3] PROSTACYCLIN (EPOPROSTENOL NA) INFUSION IMPROVES ERYTHROCYTE FILTERABILITY
    JOUVE, R
    JUHAN, I
    SERRADIMIGNI, A
    JOURNAL DE PHARMACOLOGIE, 1986, 17 (03) : 452 - 452
  • [4] Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension
    Kähler, CM
    Graziadei, I
    Wiedermann, CJ
    Kneussl, MP
    Vogel, W
    WIENER KLINISCHE WOCHENSCHRIFT, 2000, 112 (14) : 637 - 640
  • [5] Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
    Krowka, MJ
    Frantz, RP
    McGoon, MD
    Severson, C
    Plevak, DJ
    Wiesner, RH
    HEPATOLOGY, 1999, 30 (03) : 641 - 648
  • [6] Continuous infusion of prostacyclin improves plasma markers of endothelial cell injury in primary pulmonary hypertension
    Friedman, R
    Mears, JG
    Barst, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 7945 - 7945
  • [7] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    Barst, RJ
    Rubin, LJ
    Long, WA
    McGoon, MD
    Rich, S
    Badesch, DB
    Groves, BM
    Tapson, VF
    Bourge, RC
    Brundage, BH
    Koerner, SK
    Langleben, D
    Keller, CA
    Murali, S
    Uretsky, BF
    Clayton, LM
    Jobsis, MM
    Blackburn, SD
    Shortino, D
    Crow, JW
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05): : 296 - 301
  • [8] Effects and problems of continuous infusion of epoprostenol for patients with primary pulmonary hypertension
    Takahashi, T
    Sakuma, M
    Ikeda, J
    Nawata, J
    Demachi, J
    Kitamukai, O
    Shirato, K
    INTERNAL MEDICINE, 2002, 41 (10) : 784 - 788
  • [9] Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension
    Hinderliter, AL
    Willis, PW
    Barst, RJ
    Rich, S
    Rubin, LJ
    Badesch, DB
    Groves, BM
    McGoon, MD
    Tapson, VF
    Bourge, RC
    Brundage, BH
    Koerner, SK
    Langleben, D
    Keller, CA
    Murali, S
    Uretsky, BF
    Koch, G
    Li, S
    Clayton, LM
    Jobsis, MM
    Blackburn, SD
    Crow, JW
    Long, WA
    CIRCULATION, 1997, 95 (06) : 1479 - 1486
  • [10] Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost
    Higenbottam, TW
    Butt, AY
    Dinh-Xaun, AT
    Takao, M
    Cremona, G
    Akamine, S
    HEART, 1998, 79 (02) : 175 - 179
12345